StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Eupraxia Pharmaceuticals Inc.
Toronto Stock Exchange:EPRX.TO
Sector
Industries
Location
Market Cap
USD 196.83 M
Share Price
USD 5.49
Avg Daily Volume
36,993
Change (1 day)
-1.44%
Change (1 year)
102.44%
Change (YTD)
75.19%
Eupraxia Pharmaceuticals Inc. Operating Income for the year ending December 31, 2024: USD -25.71 M
Eupraxia Pharmaceuticals Inc. Operating Income is USD -25.71 M for the year ending December 31, 2024, a -7.66% change year over year. Operating income is the profit earned by a company from its normal business operations before interest and taxes are deducted.
-
Eupraxia Pharmaceuticals Inc. Operating Income for the year ending December 31, 2023 was USD -27.84 M, a 66.72% change year over year.
-
Eupraxia Pharmaceuticals Inc. Operating Income for the year ending December 31, 2022 was USD -16.70 M, a 1.19% change year over year.
-
Eupraxia Pharmaceuticals Inc. Operating Income for the year ending December 31, 2021 was USD -16.50 M, a 836.28% change year over year.
-
Eupraxia Pharmaceuticals Inc. Operating Income for the year ending December 31, 2020 was USD -1.76 M, a -62.73% change year over year.
Competitors
AbbVie Inc.
USD 191.52
ABBV
-0.93
-0.48%
Novo Nordisk A/S
USD 69.36
NOVO-B.CO
+0.76
1.10%
Roche Holding AG
USD 343.85
RO.SW
+0.20
0.06%
Novartis AG
USD 120.84
NOVN.SW
+0.06
0.05%
Abbott Laboratories
USD 132.03
ABT
+0.01
0.01%
AstraZeneca PLC
USD 143.15
AZN.L
+2.25
1.60%
Merck & Co., Inc.
USD 83.67
MRK
+0.31
0.37%
Thermo Fisher Scientific Inc.
USD 425.34
TMO
-9.52
-2.19%
Amgen Inc.
USD 297.03
AMGN
+1.76
0.60%
Boston Scientific Corporation
USD 104.33
BSX
+1.13
1.09%
Pfizer Inc.
USD 25.35
PFE
-0.30
-1.17%
Gilead Sciences, Inc.
USD 112.09
GILD
+2.45
2.23%
Vertex Pharmaceuticals Incorporated
USD 472.35
VRTX
+3.50
0.75%
Sanofi
USD 97.44
SAN.PA
+0.39
0.41%
Bristol-Myers Squibb Company
USD 47.34
BMY
+0.48
1.02%
GSK plc
USD 19.13
GSK.L
+0.13
0.71%
CSL Limited
USD 163.16
CSL.AX
+5.04
3.19%
Chugai Pharmaceutical Co., Ltd.
USD 46.16
4519.T
-0.43
-0.92%
Regeneron Pharmaceuticals, Inc.
USD 570.59
REGN
+2.85
0.50%
Siemens Healthineers AG
USD 53.64
SHL.DE
-0.22
-0.40%
Key Data
| Date | Operating Income | EBIT | EBITDA | Net Income |
|---|
Competitors
AbbVie Inc.
USD 191.52
ABBV
-0.93
-0.48%
Novo Nordisk A/S
USD 69.36
NOVO-B.CO
+0.76
1.10%
Roche Holding AG
USD 343.85
RO.SW
+0.20
0.06%
Novartis AG
USD 120.84
NOVN.SW
+0.06
0.05%
Abbott Laboratories
USD 132.03
ABT
+0.01
0.01%
AstraZeneca PLC
USD 143.15
AZN.L
+2.25
1.60%
Merck & Co., Inc.
USD 83.67
MRK
+0.31
0.37%
Thermo Fisher Scientific Inc.
USD 425.34
TMO
-9.52
-2.19%
Amgen Inc.
USD 297.03
AMGN
+1.76
0.60%
Boston Scientific Corporation
USD 104.33
BSX
+1.13
1.09%
Pfizer Inc.
USD 25.35
PFE
-0.30
-1.17%
Gilead Sciences, Inc.
USD 112.09
GILD
+2.45
2.23%
Vertex Pharmaceuticals Incorporated
USD 472.35
VRTX
+3.50
0.75%
Sanofi
USD 97.44
SAN.PA
+0.39
0.41%
Bristol-Myers Squibb Company
USD 47.34
BMY
+0.48
1.02%
GSK plc
USD 19.13
GSK.L
+0.13
0.71%
CSL Limited
USD 163.16
CSL.AX
+5.04
3.19%
Chugai Pharmaceutical Co., Ltd.
USD 46.16
4519.T
-0.43
-0.92%
Regeneron Pharmaceuticals, Inc.
USD 570.59
REGN
+2.85
0.50%
Siemens Healthineers AG
USD 53.64
SHL.DE
-0.22
-0.40%